Follow the 扶桑薬品工業株式会社 share price and the full directors' dealings record of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the authority of EDINET (Japan FSA). Market capitalisation: €19.8bn. The latest transaction was filed on 5 June 2026 (Holding update). Among the most active insiders: SMBC Nikko Securities Inc.. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 18,008 of 29,063 companies
44.6
score / 100
Value
54
Quality
36
FCF yld-41%
Earn yld11%
EV/EBITDA8.8x
ROE6.4%
Gross mgn26%
Net mgn3.2%
Debt/EBITDA5.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.